Murat Özdede

A 2010 graduate of Hacettepe University Faculty of Medicine (English), Dr. Murat Özdede began specialty training in the Department of Internal Medicine, again at Hacettepe University, in 2013 and became an Internal Medicine Specialist in 2017. After fulfilling the state service obligation at Safranbolu State Hospital and Karabük Training and Research Hospital between 2017 and 2020, began working in 2020 as a lecturer in the Division of General Internal Medicine, Department of Internal Medicine, Hacettepe University Faculty of Medicine. In 2025, became eligible for the title of Associate Professor in Internal Medicine.

Between 2024 and 2025, worked as a Research Fellow at King’s College London and, during the same period, served as a clinical observer in the acute internal medicine clinic at Cambridge Addenbrooke’s Hospital.

Member of numerous national and international societies related to the field.

1. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching-right-to-replyÖZDEDE M., BALLI TURHAN F. N., Geridönmez Ö., KARA E., METAN G.Journal of Antimicrobial Chemotherapy, cilt.81, sa.10, 2026 (SCI-Expanded, Scopus)
2. Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohortÖZDEDE M., Yadigar S., GÜVEN A. T., Akgür S., Arslan F., Sezen M., et al.Clinical Kidney Journal, cilt.19, sa.8, 2026 (SCI-Expanded, Scopus)
3. Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort StudyGÜVEN A. T., Yadigar S., ÖZDEDE M., Akgür S., Arslan F., Sezen M., et al.Journal of Clinical Medicine, cilt.15, sa.15, 2026 (SCI-Expanded, Scopus)
4. The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetesOzdede M., Pavlou P., Krasniqi V., Athanasiadou K. I., Ayis S., Thomas S., et al.Diabetologia, cilt.69, sa.7, ss.2061-2072, 2026 (SCI-Expanded, Scopus)
5. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matchingÖZDEDE M., BALLI TURHAN F. N., Geridönmez Ö., KARA E., METAN G.Journal of Antimicrobial Chemotherapy, cilt.81, sa.6, 2026 (SCI-Expanded, Scopus)
6. Older adults bear the burden: risk factors for severe influenza outcomes among hospitalized adults in a 9-season multicenter active surveillance studyÖZIŞIK L., DURUSU TANRIÖVER M., ÖZDEDE M., BAĞCI BOSI A. T., ÇAKIR B., Badur S., et al.Medicine, cilt.105, sa.19, 2026 (SCI-Expanded, Scopus)
7. Prognostic Significance of SULF2 Expression in Surgically Resected Non-Small Cell Lung CancerTaban H., ÖZDEDE M., AKMAN O., ÖNDER S. Ç., Kılıckap S.Medical sciences (Basel, Switzerland), cilt.14, sa.2, 2026 (ESCI, Scopus)
8. Combined low-volume high-intensity interval training and inspiratory muscle training in patients with metabolic syndrome: A randomized controlled trialUyar H., VARDAR YAĞLI N., SAĞLAM M., ÇALIK E., UYAROĞLU O. A., ÖZDEDE M., et al.Medicine, cilt.105, sa.17, 2026 (SCI-Expanded, Scopus)
9. Association between Hashimoto’s thyroiditis and hemoglobin-albumin-lymphocyte-platelet score and systemic inflammatory index: a nationwide cohort studyAtak Tel B. M., Biçer I., BAVUNOĞLU I., Düzen Oflas N., ŞAHİN TEKİN M., Sen H., et al.Postgraduate Medicine, cilt.138, sa.1, ss.63-70, 2026 (SCI-Expanded, Scopus)
10. Urinary Biomarker Profiles Define Divergent Pathways in Albuminuric and Non-Albuminuric Diabetic Kidney DiseaseKAYGUSUZ Y., Özbek D. A., ERDUT A., Abanoz R., Korkut M. G., ÖZDEDE M., et al.Kidney Diseases, cilt.12, sa.1, ss.330-345, 2026 (SCI-Expanded, Scopus)
11. Internal Medicine Physicians’ Reflections on AI Tools for Research Tasks in Turkey: A Qualitative Descriptive Study Following a Brief Educational SessionZorlu Görgülügil G., ÖZDEDE M., Özbilen M., Polat Z. P., Genç A. C., Şahin S. E., et al.Advances in Medical Education and Practice, cilt.17, 2026 (ESCI, Scopus)
12. Beyond linearity and static risk: re-evaluating core prognostic factors in diffuse large B-cell lymphomaIsmayilov R., ÖZDEDE M., BÜYÜKAŞIK Y.Expert Review of Hematology, cilt.19, sa.5, ss.563-570, 2026 (SCI-Expanded, Scopus)
13. Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainmentAKMAN AR E. D., KARA E., Karadoğan E., ÖZDEDE M., PINAR A., UZUN Ö., et al.European Journal of Hospital Pharmacy, 2026 (SCI-Expanded, Scopus)
14. In-depth assessment of steatotic liver disease awareness in high-risk groupsÖZDEDE M., Guven A. T., ÇELİK EROĞLU B.JOURNAL OF EVALUATION IN CLINICAL PRACTICE, cilt.31, sa.1, 2025 (SCI-Expanded, Scopus)
15. Improved outcome prediction in acute pancreatitis with generated data and advanced machine learning algorithmsÖZDEDE M., BATUR A., Aksoy A. E.TURKISH JOURNAL OF EMERGENCY MEDICINE, cilt.25, sa.1, ss.32-40, 2025 (ESCI, Scopus, TRDizin)
16. Fazla kilolu ve obez hastaların obezite tedavilerine yönelik tutumları ve tutumla ilişkili faktörlerGÜVEN A. T., ÖZDEDE M., KAYAOĞLU B., ŞERİFLİ N., ÖZÇİÇEK A., GELERİ T. I.Sakarya Tıp Dergisi, cilt.14, sa.3, ss.254-267, 2024 (TRDizin)
17. Oxygen uptake efficiency, chronotropic ıncompetence and abnormal heart rate recovery during exercise in individuals with metabolic syndromeSANVER M. F., Uyar H., SAĞLAM M., ÇALIK KÜTÜKCÜ E., UYAROĞLU O. A., ÖZDEDE M., et al.EUROPEAN RESPIRATORY JOURNAL, 2024 (SCI-Expanded, Scopus)
18. Monogenic Hypertension Linked to the Renin - Angiotensin-Aldosterone SystemÖZDEDE M.ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.28, sa.9, ss.417-428, 2024 (SCI-Expanded, Scopus, TRDizin)
19. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: commentÖZDEDE M., Güven A. T.Internal and Emergency Medicine, cilt.19, sa.3, ss.879-881, 2024 (SCI-Expanded, Scopus)
20. Weight Misperception is Prevalent Among Turkish Adults and Associated with Higher Age, Body Mass Index and Lower Education StatusGuven A. T., ÖZDEDE M., ÇELİK EROĞLU B.DIABETES METABOLIC SYNDROME AND OBESITY, cilt.17, ss.2831-2843, 2024 (SCI-Expanded, Scopus)
21. Baseline Sodium-Glucose Cotransporter-2 Inhibitor Use Strongly Attenuates the Uric Acid-Elevating Effect of Thiazide ExposureGuven A. T., ÖZDEDE M., ŞENER Y. Z.EUROPEAN JOURNAL OF THERAPEUTICS, cilt.29, sa.4, ss.741-747, 2023 (ESCI, TRDizin)
22. Machine Learning Insights Into Uric Acid Elevation With Thiazide Therapy Commencement and IntensificationÖZDEDE M., Guven A. T.CUREUS JOURNAL OF MEDICAL SCIENCE, sa.12, 2023 (ESCI)

1. SS-044 BETY-BQ ÖLÇEĞİNİN TİP 2 DİABETES MELLUTUS TANILI BİREYLERDE GEÇERLİĞİ VE GÜVENİRLİĞİNİN İNCELENMESİ –PİLOT ÇALIŞMATüfekçi O., BURAN S., KARACA N. B., ÖZDEDE M., UYAROĞLU O. A., ÜNAL E., et al.25. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.69-70, (Özet Bildiri)
2. ERİŞKİN İMMÜNYETMEZLİKLİ HASTALARDA SAĞLIKLA İLİŞKİLİ YAŞAM KALİTESİ VE ÇALIŞMA DURUMLARININ BELİRLENMESİMADEN S., ÖZDEDE M., ÖZDEMİRAL C., ESENBOĞA S., SÖNMEZER M. Ç., İNKAYA A. Ç., et al.25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 8 Aralık - 12 Kasım 2023, (Tam Metin Bildiri)
3. Can plasma lipid levels be correlated to severe COVID-19 infection?UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., KÖYLÜ B., ŞAHİN T. K., ÖZIŞIK L., et al.Atherosclerosis, Helsinki, Finlandiya, 28 Haziran 2021, (Özet Bildiri)
4. Metabolik Sendromlu Hastalarda Yüksek Yoğunluklu İnterval Eğitim ile Kombine Solunum Kas Eğitiminin EtkileriUYAR H., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., UYAROĞLU O. A., ÖZDEDE M., DURUSU TANRIÖVER M.
5. İZOLE GGT YÜKSEKLİĞİNİN KARDİYOVASKÜLER HASTALIK RİSKİ VE METABOLİK SENDROM İLE İLİŞKİSİÖztürk Z. Ö., UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., SAİN GÜVEN G., et al.

1. Özel erişkin gruplarda aşılamaÖZDEDE M., ÇALIK BAŞARAN N.